Word From Washington: CMS Drops Proposal to Allow Medicare Plans to Limit Coverage of "Protected Class" Drugs
The U.S. Centers for Medicare and Medicaid Services (CMS) released a final rule yesterday on drug pricing in the Medicare Advantage and Medicare Part D programs.In its final rule, CMS chose not to implement a harmful change that it had initially put forward – a change strongly opposed by HFA and numerous other patient groups.Longstanding federal […]